The Revolutionary Fecal Matter-Based Drug: A Game Changer for Cancer Patients
2 days ago
A groundbreaking study has revealed that a novel drug derived from fecal matter has shown significant potential in aiding cancer patients who are battling a severe and often deadly complication known as acute gastrointestinal graft-versus-host disease (aGVHD). This condition typically arises in individuals who have undergone stem cell transplants, whereby the donor’s immune cells attack the recipient’s gastrointestinal tract, leading to severe complications.
Continue reading